Key Takeaway
Blood work is the backbone of safe and effective GH peptide therapy. Without it, you're guessing. With it, you and your provider can confirm that your peptide protocol is working, catch potential issues early, and improve your dosing for the best results.
Blood work is the backbone of safe and effective GH peptide therapy. Without it, you're guessing. With it, you and your provider can confirm that your peptide protocol is working, catch potential issues early, and improve your dosing for the best results.
Key Takeaways: - important Baseline Labs Before Starting - Follow-Up Labs During Your Protocol - Understanding Your IGF-1 Results - Red Flags in Your Blood Work
This guide covers which labs to get, when to get them, and how to interpret the results in the context of GH peptide blood work monitoring.
important Baseline Labs Before Starting
Before your first dose of any GH peptide, your provider should order a thorough panel. This establishes your starting point and screens for any contraindications.
IGF-1 (Insulin-like Growth Factor 1) is the single most important marker. IGF-1 is produced by the liver in response to growth hormone. Because GH is released in pulses and fluctuates throughout the day, measuring GH directly isn't practical. IGF-1 levels are stable and give a reliable picture of your overall GH status.
Normal IGF-1 ranges vary by age and sex. Your provider will evaluate your level in context) not just whether it's "in range" but where it falls within the range and how it relates to your symptoms.
Fasting glucose and fasting insulin. Growth hormone can affect blood sugar regulation. Some GH peptides (particularly MK-677) can reduce insulin sensitivity. Baseline glucose and insulin levels help your provider monitor for metabolic changes during therapy.
"We now have cardiovascular outcomes data showing semaglutide reduces MACE events by 20% in people with obesity, independent of diabetes status. The SELECT trial[1] changed how we think about these medications.", Dr. A. Michael Lincoff, MD, Cleveland Clinic, lead author of SELECT
HbA1c. This measures your average blood sugar over the past 2 to 3 months. It's a better long-term indicator of glucose control than a single fasting glucose reading. If your HbA1c is improved at baseline, your provider needs to know before starting GH peptide therapy.
Complete metabolic panel (CMP). This standard panel covers kidney function, liver function, and electrolytes. It ensures your organs can safely process the peptide and screens for conditions that might affect your protocol.
Thyroid panel (TSH, free T3, free T4). GH can affect thyroid hormone metabolism. In some cases, GH therapy can unmask subclinical hypothyroidism or alter how your body converts T4 to active T3. Baseline thyroid levels are important. Learn more about .
Lipid panel. Total cholesterol, LDL, HDL, and triglycerides. GH can affect lipid metabolism. Tracking changes from baseline helps assess the full metabolic impact of your protocol.
Prolactin. Relevant if you're using GHRP-6 or GHRP-2, which can improve prolactin. Even with (which doesn't typically raise prolactin), having a baseline is good practice.
Follow-Up Labs During Your Protocol
Once you're on a GH peptide protocol, your provider should order follow-up labs at specific intervals.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
4-6 weeks after starting: This is the critical first check. The primary goals are to confirm that IGF-1 has increased from baseline (meaning the peptide is working), to ensure IGF-1 hasn't risen too high (meaning the dose may need adjustment), to check fasting glucose for any early metabolic changes, and to review any concerning trends in other markers.
At the midpoint of your cycle (typically week 6-8 for a 12-week cycle): Another IGF-1 check to ensure levels are stable. Repeat fasting glucose and insulin. Thyroid panel if there were any baseline concerns.
At the end of each cycle (week 12): Full panel repeat. This check helps your provider decide whether to continue at the same dose, adjust dosing, or modify your protocol for the next cycle.
During off-cycle breaks: Some providers check IGF-1 during the break to see how quickly your levels return to baseline. This helps assess your natural GH production capacity. It's also useful for confirming that your pituitary is still producing GH independently.
Track when your blood draws are scheduled using the . Many providers integrate with mobile health platforms, making it easier to share and review results together.
Free Download: Peptide Protocol Planner (12-Week) Our 12-week planner includes blood work scheduling reminders, result tracking templates, and provider discussion guides for each lab review. Get yours free (we'll email it to you instantly.
[Download CTA Button]
How Your IGF-1 Results
IGF-1 is the marker you'll focus on most. Here's how to think about the numbers.
From the FormBlends catalog
CJC-1295 / Ipamorelin Blend
The gold standard growth hormone secretagogue stack · From $69/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about CJC-1295 / Ipamorelin Blend →Reference ranges vary by lab and are age-stratified. For example, a normal range for a 40-year-old might be 87-267 ng/mL, while for a 60-year-old it might be 75-228 ng/mL. Your provider will use age-appropriate ranges.
Optimal vs. Normal. Being "in range" doesn't necessarily mean your levels are optimal. Many providers target the upper third of the age-adjusted normal range for health improvement. For example, if your range is 87-267 ng/mL, the improvement target might be 200-260 ng/mL.
Too high is problematic. If IGF-1 rises above the normal range, your provider should reduce your dose. Chronically improved IGF-1 has been associated with increased health risks in some population studies. The goal is improvement, not maximization.
Poor response. If IGF-1 doesn't increase after 4-6 weeks, it could mean the dose is too low, the peptide quality is poor, you're taking it with food (insulin blunts GH release), or there's an absorption issue. Your provider can troubleshoot.
Individual variation. Some people are "high responders" who see large IGF-1 increases from modest doses. Others are "low responders" who need higher doses. Neither is inherently better) it's about finding the right dose for your body.
Always fast for 8-12 hours before IGF-1 blood draws. Morning draws are preferred for consistency. Try to draw labs at the same time of day for accurate comparisons across cycles.
Red Flags in Your Blood Work
Certain patterns in your blood work should prompt a conversation with your provider.
Rising fasting glucose or insulin. If fasting glucose increases by more than 10 mg/dL or insulin levels trend upward, your provider may need to adjust your protocol. This is particularly important with MK-677 or higher-dose protocols. Understanding is important for safe therapy.
IGF-1 above the reference range. This means your GH levels are too high. Your provider should reduce the dose. Symptoms like hand tingling, joint pain, or significant water retention often accompany improved IGF-1.
Thyroid function changes. A decrease in free T3 or increase in TSH during peptide therapy may indicate that GH is affecting thyroid metabolism. Your provider may need to address thyroid function to maximize the benefits of your peptide protocol.
improved prolactin. Relevant primarily for GHRP-6 or GHRP-2 users. improved prolactin can affect mood, libido, and hormonal balance. Switching to Ipamorelin usually resolves this issue.
Liver enzyme elevation. Significant increases in ALT or AST should be evaluated. While mild fluctuations are usually benign, large increases warrant investigation.
Your provider should review your complete lab panel (not just IGF-1) at every follow-up. A takes a complete approach to monitoring, looking at the full picture rather than isolated numbers.
Frequently Asked Questions
How much does GH peptide blood work cost?
Costs vary by lab and panel. A basic IGF-1 test may cost $50-100 out of pocket. A detailed baseline panel including IGF-1, metabolic panel, thyroid, and lipids typically runs $200-400. Some providers include lab costs in their program fees. Check for details.
Can I use at-home blood testing kits?
Some direct-to-consumer lab companies offer IGF-1 testing. These can be convenient for between-visit monitoring. But baseline and critical follow-up labs should ideally be done through your provider's preferred laboratory for consistency and accuracy.
What time of day should I get blood drawn?
Morning draws (8-10 AM) after an overnight fast are standard. IGF-1 is relatively stable throughout the day, but glucose and insulin readings are most accurate when fasting. Consistency matters (try to draw at the same time for each test.
Do I need blood work during off-cycle breaks?
Some providers check IGF-1 during the off period to see how your natural production looks without peptide support. This isn't always required but can provide useful information about your pituitary function and help plan future cycles.
What if my provider doesn't order complete blood work?
Detailed monitoring is a hallmark of responsible peptide therapy. If your provider doesn't order baseline and follow-up labs, consider it a red flag. Safe GH peptide therapy requires objective data) not just subjective assessments. A quality provider will make blood work a non-negotiable part of your protocol.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Medical References
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702
The information in this article is intended for educational use only and shouldn't be considered medical advice. Consult a qualified healthcare provider before making any changes to your medication or supplement regimen. FormBlends helps with connections with licensed providers for personalized medical guidance.
Last updated: 2026-03-24
Ready when you are
CJC-1295 / Ipamorelin Blend
The gold standard growth hormone secretagogue stack · From $69/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about CJC-1295 / Ipamorelin Blend →